Significantly downregulated pathways found with KITLG were hematopoietic cell lineage, melanogenesis, Rap1 signaling, mitogen-activated protein kinase (MAPK) signaling, P13/AKT signaling, pathways in cancer, PLD signaling, and Ras signaling. This evidence concerns the gene KITLG and cancer.